• 1
    Department of Veterans Affairs. Veterans Affairs Central Cancer Registry (VACCR). Washington, DC: Department of Veterans Affairs, Veterans Health Administration; 2012.
  • 2
    Finlayson SR, Birkmeyer JD, Tosteson AN, Nease RF Jr. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37:204209.
  • 3
    Mooney C, Zwanziger J, Phibbs CS, Schmitt S. Is travel distance a barrier to veterans' use of VA hospitals for medical surgical care? Soc Sci Med. 2000;50:17431755.
  • 4
    Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services: a review of barriers to quality care. Cancer. 1999;86:23782390.
  • 5
    Weeks WB, Wallace AE, West AN, Heady HR, Hawthorne K. Research on rural veterans: an analysis of the literature. J Rural Health. 2008;24:337344.
  • 6
    Goins RT, Williams KA, Carter MW, Spencer M, Solovieva T. Perceived barriers to health care access among rural older adults: a qualitative study. J Rural Health. 2005;21:206213.
  • 7
    Baldwin LM, Patel S, Andrilla CH, Rosenblatt RA, Doescher MP. Receipt of recommended radiation therapy among rural and urban cancer patients. Cancer. 2012;118:51005109.
  • 8
    Doolittle GC, Spaulding AO. Providing access to oncology care for rural patients via telemedicine. J Oncol Pract. 2006;2:228230.
  • 9
    Spoont M, Greer N, Su J, Fitzgerald P, Rutks I, Wilt T. Rural vs. Urban Ambulatory Healthcare: A Systematic Review. VA-ESP Project 09–009. Washington, DC: Department of Veterans Affairs; 2011.
  • 10
    Nelson RE, Hicken B, West A, Rupper R. The effect of increased travel reimbursement rates on health care utilization in the VA. J Rural Health. 2012;28:192201.
  • 11
    Veterans Health Administration Office of Rural Health (ORH). Available at: Accessed October 24, 2012.
  • 12
    Mackinney AC, Mueller KJ, McBride TD. The march to accountable care organizations-how will rural fare? J Rural Health. 2011;27:131137.
  • 13
    Wood D. The move to accountable care organizations includes telemedicine. Telemed J E Health. 2011;17:237240.
  • 14
    Washington State Department of Health. Guidelines for Using Rural-Urban Classification Systems for Public Health Assessment. Seattle, WA: Washington State Department of Health; 2008.
  • 15
    Gresenz CR, Rogowski J, Escarce JJ. Health care markets, the safety net, and utilization of care among the uninsured. Health Serv Res. 2007;42(1 pt 1):239264.
  • 16
    Haynes R, Jones AP, Sauerzapf V, Zhao H. Validation of travel times to hospital estimated by GIS [serial online]. Int J Health Geogr. 2006;5:40.
  • 17
    Program Evaluation of Oncology Programs in the Veterans Health Administration, Survey of Department of Veterans Affairs Medical Centers. Office of Policy, Planning, and Preparedness. Final Report, March 2006. Cambridge, MA: Abt Associates Inc., Harvard Medical School; 2006.
  • 18
    Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. Contemporary trends in imaging test utilization for prostate cancer staging: data from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2002;168:491495.
  • 19
    Palvolgyi R, Daskivich TJ, Chamie K, Kwan L, Litwin MS. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology. 2011;77:13301336.
  • 20
    North Central Cancer Network (NCCN).NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer, Version 3.2012. Available at: Accessed June 1, 2012.
  • 21
    American Urological Association Education and Research, Inc. Prostate-Specific Antigen Best Practice Statement: 2009 Update. Linthium Heights, MD: American Urological Association Education and Research, Inc.; 2009.
  • 22
    Miller DC, Murtagh DS, Suh RS, Knapp PM, Dunn RL, Montie JE. Establishment of a urological surgery quality collaborative. J Urol. 2010;184:24852490.
  • 23
    Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:12331239.
  • 24
    Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351:15131520.
  • 25
    Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet. 2002;360:103106.
  • 26
    D'Amico AV, Denham JW, Bolla M, et al. Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate. Cancer. 2007;109:20042010.
  • 27
    Schooley BL, Horan TA, Lee PW, West PA. Rural veteran access to healthcare services: investigating the role of information and communication technologies in overcoming spatial barriers [serial online]. Perspect Health Inf Manag. 2010;7:1f.
  • 28
    Disabled American Veterans (DAV).DAV Hospital Service Coordinator Directory. Available at: Accessed October 12, 2012.
  • 29
    Obertova Z, Brown C, Holmes M, Lawrenson R. Prostate cancer incidence and mortality in rural men—a systematic review of the literature [serial online]. Rural Remote Health. 2012;12:2039.
  • 30
    Nambudiri VE, Landrum MB, Lamont EB, et al. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Urology. 2012;79:537545.
  • 31
    Department of Veterans Affairs,Veterans Health Administration (VHA).VHA Directive 2003–034. Available at: Accessed June 1, 2012.
  • 32
    Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008;113:24642470.
  • 33
    Keating NL, Landrum MB, Lamont EB, et al. Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med. 2011;154:727736.
  • 34
    Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment—Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010;52:11241133.
  • 35
    Stoves J, Connolly J, Cheung CK, et al. Electronic consultation as an alternative to hospital referral for patients with chronic kidney disease: a novel application for networked electronic health records to improve the accessibility and efficiency of healthcare [serial online]. Qual Saf Health Care. 2010;19:e54.
  • 36
    Kehle SM, Greer N, Rutks I, Wilt T. Interventions to improve veterans' access to care: a systematic review of the literature. J Gen Intern Med. 2011;26(suppl 2):689696.